A Polygenic Risk Score of Atrial Fibrillation Improves Prediction of Lifetime Risk for Heart Failure
Authors:
Open Access
- 22 January 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 11 (2) , 1086-1096
Abstract
Aims: Heart failure (HF) has shared genetic architecture with its risk factors: atrial fibrillation (AF), body mass index (BMI), coronary heart disease (CHD), systolic blood pressure (SBP), and type 2 diabetes (T2D). We aim to assess the association and risk prediction performance of risk-factor polygenic risk scores (PRSs) for incident HF and its subtypes in bi-racial populations. Methods and results: Five PRSs were constructed for AF, BMI, CHD, SBP, and T2D in White participants of the Atherosclerosis Risk in Communities (ARIC) study. The associations between PRSs and incident HF and its subtypes were assessed using Cox models, and the risk prediction performance of PRSs was assessed using C statistics. Replication was performed in the ARIC study Black and Cardiovascular Health Study (CHS) White participants. In 8624 ARIC study Whites, 1922 (31% cumulative incidence) HF cases developed over 30 years of follow-up. PRSs of AF, BMI, and CHD were associated with incident HF (P < 0.001), where PRSAF showed the strongest association [hazard ratio (HR): 1.47, 95% confidence interval (CI): 1.41–1.53]. Only the addition of PRSAF to the ARIC study HF risk equation improved C statistics for 10 year risk prediction from 0.812 to 0.829 (∆C: 0.017, 95% CI: 0.009–0.026). The PRSAF was associated with both incident HF with reduced ejection fraction (HR: 1.43, 95% CI: 1.27–1.60) and incident HF with preserved ejection fraction (HR: 1.46, 95% CI: 1.33–1.62). The associations between PRSAF and incident HF and its subtypes, as well as the improved risk prediction, were replicated in the ARIC study Blacks and the CHS Whites (P < 0.050). Protein analyses revealed that N-terminal pro-brain natriuretic peptide and other 98 proteins were associated with PRSAF. Conclusions: The PRSAF was associated with incident HF and its subtypes and had significant incremental value over an established HF risk prediction equation.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (U01HL130114)
- National Heart, Lung, and Blood Institute (R01HL120393)
- National Heart, Lung, and Blood Institute (R01HL103612)
- National Heart, Lung, and Blood Institute (R01HL087652)
- National Heart, Lung, and Blood Institute (U01HL080295)
- National Heart, Lung, and Blood Institute (75N92021D00006)
- National Heart, Lung, and Blood Institute (N01HC85086)
- National Heart, Lung, and Blood Institute (N01HC85083)
- National Heart, Lung, and Blood Institute (N01HC85082)
- National Heart, Lung, and Blood Institute (N01HC85081)
- National Heart, Lung, and Blood Institute (N01HC85080)
- National Heart, Lung, and Blood Institute (N01HC85079)
- National Heart, Lung, and Blood Institute (N01HC55222)
- National Heart, Lung, and Blood Institute (HHSN268201800001C)
- National Heart, Lung, and Blood Institute (HHSN268200800007C)
- National Heart, Lung, and Blood Institute (HHSN268201200036C)
- National Heart, Lung, and Blood Institute (K24HL152008)
- National Heart, Lung, and Blood Institute (R01HL150342)
- National Heart, Lung, and Blood Institute (R01HL143224)
- National Heart, Lung, and Blood Institute (R01HL135008)
- National Heart, Lung, and Blood Institute (R01HL160793)
- National Heart, Lung, and Blood Institute (R01HL148218)
- National Heart, Lung, and Blood Institute (R01HL141824)
- National Heart, Lung, and Blood Institute (R01HL134320)
- National Heart, Lung, and Blood Institute (R01HL105756)
- National Heart, Lung, and Blood Institute (R01HL086694)
- National Heart, Lung, and Blood Institute (R01HL059367)
- National Heart, Lung, and Blood Institute (R01HL087641)
- National Institutes of Health (UL1RR025005)
- National Institutes of Health (HHSN268200625226C)
- National Institutes of Health (HHSN268201700005I)
- National Institutes of Health (HHSN268201700004I)
- National Institutes of Health (HHSN268201700003I)
- National Institutes of Health (HHSN268201700002I)
- National Institutes of Health (HHSN268201700001I)
- National Human Genome Research Institute (U01HG004402)
- National Institute on Aging (R01AG023629)
- National Heart, Lung, and Blood Institute (U01HL130114)
- National Heart, Lung, and Blood Institute (R01HL120393)
- National Heart, Lung, and Blood Institute (R01HL103612)
- National Heart, Lung, and Blood Institute (R01HL087652)
- National Heart, Lung, and Blood Institute (U01HL080295)
- National Heart, Lung, and Blood Institute (75N92021D00006)
- National Heart, Lung, and Blood Institute (N01HC85086)
- National Heart, Lung, and Blood Institute (N01HC85083)
- National Heart, Lung, and Blood Institute (N01HC85082)
- National Heart, Lung, and Blood Institute (N01HC85081)
- National Heart, Lung, and Blood Institute (N01HC85080)
- National Heart, Lung, and Blood Institute (N01HC85079)
- National Heart, Lung, and Blood Institute (N01HC55222)
- National Heart, Lung, and Blood Institute (HHSN268201800001C)
- National Heart, Lung, and Blood Institute (HHSN268200800007C)
- National Heart, Lung, and Blood Institute (HHSN268201200036C)
- National Heart, Lung, and Blood Institute (K24HL152008)
- National Heart, Lung, and Blood Institute (R01HL150342)
- National Heart, Lung, and Blood Institute (R01HL143224)
- National Heart, Lung, and Blood Institute (R01HL135008)
- National Heart, Lung, and Blood Institute (R01HL160793)
- National Heart, Lung, and Blood Institute (R01HL148218)
- National Heart, Lung, and Blood Institute (R01HL141824)
- National Heart, Lung, and Blood Institute (R01HL134320)
- National Heart, Lung, and Blood Institute (R01HL105756)
- National Heart, Lung, and Blood Institute (R01HL086694)
- National Heart, Lung, and Blood Institute (R01HL059367)
- National Heart, Lung, and Blood Institute (R01HL087641)
- National Institutes of Health (UL1RR025005)
- National Institutes of Health (HHSN268200625226C)
- National Institutes of Health (HHSN268201700005I)
- National Institutes of Health (HHSN268201700004I)
- National Institutes of Health (HHSN268201700003I)
- National Institutes of Health (HHSN268201700002I)
- National Institutes of Health (HHSN268201700001I)
- National Human Genome Research Institute (U01HG004402)
- National Institute on Aging (R01AG023629)
This publication has 41 references indexed in Scilit:
- Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillationNature Genetics, 2017
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Heart Journal, 2016
- Recalibration of Blood Analytes over 25 Years in the Atherosclerosis Risk in Communities Study: Impact of Recalibration on Chronic Kidney Disease Prevalence and IncidenceClinical Chemistry, 2015
- Patient Selection in Heart Failure With Preserved Ejection Fraction Clinical TrialsJACC, 2015
- 2013 ACC/AHA Guideline on the Assessment of Cardiovascular RiskCirculation, 2014
- Angiopoietin-2 in Adults with Congenital Heart Disease and Heart FailurePLOS ONE, 2013
- Prediction of Incident Heart Failure in General PracticeCirculation: Heart Failure, 2012
- Classification of Heart Failure in the Atherosclerosis Risk in Communities (ARIC) StudyCirculation: Heart Failure, 2012
- On the C‐statistics for evaluating overall adequacy of risk prediction procedures with censored survival dataStatistics in Medicine, 2011
- Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failureJACC, 2004